Medidata AI advances our mission of powering smarter treatments and healthier people by expediting the delivery of life-saving therapies to the market. We enable smart, data-driven decisions throughout clinical development programs, significantly boosting their chances of success.
From Trial to Launch
Medidata AI accelerates clinical trials and brings life-saving therapies to market. We achieve this by leveraging data-driven insights gathered from our database of over 9 million patients across more than 30,000 trials. We’re your collaborative partners in helping to optimize study design, simulate potential outcomes, and streamline the operational planning and execution of your trials.
Our solutions generate critical evidence to enhance the probability of regulatory success, improve market access, and expedite time to peak sales – revolutionizing the landscape of clinical development.
Medidata AI Offerings
Who We Are
At Medidata AI, there are hundreds of incessantly curious, multi-disciplinary experts who equip you with the vital data and tools you need to find new innovative approaches to clinical trials and to rethink the limits of what is possible — because today’s challenges demand it.
Clinical Trial Data
Medidata offers insights built upon over 30,000 trials – including 8,000 active studies – and 9 million participants. Enabling better, faster decisions that can inform site selection, ensure enrollment of diverse patient populations, design safer trial protocols, and generate evidence via an external control arm to demonstrate comparative efficacy.
Medidata offers anonymized, patient-level synthetic data that can be utilized to investigate and inform product development. We bring together the power of our historical clinical trial database with cutting-edge AI/ML techniques that preserves patient privacy while allowing expanded access to the insights contained within these valuable, siloed data sources.
The Medidata Research Alliance brings together academic and key opinion leaders with Medidata’s expert staff, comprised of clinicians, biostatisticians, former regulatory officials and industry veterans. By combining multi-sector expertise with data-driven research, we advance clinical innovations and fulfill our mission of powering smarter treatments and healthier people.
Medidata AI Solutions
From planning to launch, we are your collaborative partner — pushing the innovations realized through unparalleled clinical trial data, deep industry and human expertise, advanced analytics and predictive modeling.
Gain a competitive edge in trial planning and enrollment through real time data and analytics.
Meet your trial diversity goals and enhance site selection to choose sites that can accelerate your trial and have a track-record of successfully enrolling diverse patients, based on indication-specific cross-industry data.
Reduce trial planning uncertainty and improve the probability of regulatory and technical success through novel and proven approaches to protocol development, leveraging the insights contained within over 30,000 trials.
Synthetic Control Arm® (SCA®)
When a traditional randomized control arm is unfeasible, Medidata SCA enables teams to build an external control arm through careful selection of patient level data to yield a baseline composition that is statistically well balanced with the experimental arm.
Connect real world data to your study at the patient level to access richer insights into patient journeys, accelerate and broaden understanding of real-world outcomes, all while minimizing the burden on sites and patients.
Diversity in Clinical Trials
Announcing the launch of the industry’s most comprehensive solution for improving diversity, equity, and inclusion in clinical trials.
The Medidata Research Alliance bridges data-driven insights into clinical practice, fostering scientific exploration that can be applied across multiple therapeutic areas.
Medidata Link Wins Reagan-Udall Innovation Award
Medidata Link was awarded the prestigious 2022 Innovations in Regulatory Science Award from the Reagan-Udall Foundation for the FDA. The Innovation Award recognizes individuals or organizations that have made particularly groundbreaking contributions to regulatory science or policy to improve public health.
Get in Touch
Interested in learning more?